1 not yet recruiting. .
Follow Erwin Dreesen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic-pharmacodynamic Modeling and Simulation Study of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease Subcutaneous infliximab CT-P13 Remsima®SC - IBD - Inflammatory Bowel Disease, RA - Rheumatoid Arthritis | Not yet recruiting | Erwin Dreesen | 439 | 2025-09-01 | 2025-09-03 |